A detailed history of Bank Of America Corp transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Bank Of America Corp holds 554,945 shares of EBS stock, worth $3.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
554,945
Previous 398,063 39.41%
Holding current value
$3.82 Million
Previous $1.01 Million 275.77%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.86 - $6.98 $291,800 - $1.1 Million
156,882 Added 39.41%
554,945 $3.78 Million
Q1 2024

May 15, 2024

SELL
$1.5 - $3.41 $38,278 - $87,019
-25,519 Reduced 6.02%
398,063 $1.01 Million
Q4 2023

Feb 14, 2024

SELL
$1.82 - $3.16 $20,353 - $35,338
-11,183 Reduced 2.57%
423,582 $1.02 Million
Q2 2023

Aug 14, 2023

SELL
$7.35 - $13.21 $1.2 Million - $2.15 Million
-162,916 Reduced 27.26%
434,765 $3.2 Million
Q1 2023

May 12, 2023

BUY
$7.79 - $16.29 $2.37 Million - $4.97 Million
304,850 Added 104.1%
597,681 $6.19 Million
Q4 2022

Feb 10, 2023

BUY
$11.0 - $21.45 $1.53 Million - $2.98 Million
139,026 Added 90.39%
292,831 $3.46 Million
Q3 2022

Nov 14, 2022

SELL
$20.09 - $35.8 $1.16 Million - $2.08 Million
-57,985 Reduced 27.38%
153,805 $3.23 Million
Q2 2022

Aug 12, 2022

SELL
$27.42 - $43.63 $5.56 Million - $8.84 Million
-202,629 Reduced 48.89%
211,790 $6.57 Million
Q1 2022

May 16, 2022

SELL
$36.48 - $52.22 $1.9 Million - $2.72 Million
-52,148 Reduced 11.18%
414,419 $17 Million
Q4 2021

Feb 08, 2022

SELL
$33.11 - $55.01 $4.37 Million - $7.26 Million
-131,998 Reduced 22.05%
466,567 $20.3 Million
Q3 2021

Nov 15, 2021

BUY
$50.07 - $66.05 $17.5 Million - $23.1 Million
349,327 Added 140.16%
598,565 $30 Million
Q2 2021

Sep 13, 2021

BUY
$56.61 - $80.46 $14.1 Million - $20.1 Million
249,238 New
249,238 $15.7 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $343M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.